VRCA Verrica Pharmaceuticals Inc

USD 5.65 0.33 (+6.20%)
Icon

Verrica Pharmaceuticals Inc (VRCA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.65

+0.33 (+6.20)%

USD 0.21B

0.21M

USD 9.75(+72.57%)

USD 0.00 (-100.00%)

Icon

VRCA

Verrica Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 5.65
0.33 (+6.20%)
At close: 04:00PM EDT
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.21B

USD 0.00 (-100.00%)

USD 5.65

Verrica Pharmaceuticals Inc (VRCA) Stock Forecast

Show ratings and price targets of :
USD 9.75
(+72.57%)

Based on the Verrica Pharmaceuticals Inc stock forecast from 3 analysts, the average analyst target price for Verrica Pharmaceuticals Inc is USD 9.75 over the next 12 months. Verrica Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Verrica Pharmaceuticals Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Verrica Pharmaceuticals Inc’s stock price was USD 5.65. Verrica Pharmaceuticals Inc’s stock price has changed by +13.91% over the past week, -0.35% over the past month and -12.40% over the last year.

No recent analyst target price found for Verrica Pharmaceuticals Inc
No recent average analyst rating found for Verrica Pharmaceuticals Inc

Company Overview Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the United States. Its product pipeline comprises YCANTH (VP-102), which is in phase III clinical trial for the treatment of common warts; a...Read More

https://www.verrica.com

44 West Gay Street, West Chester, PA, United States, 19380

100

December

USD

USA

Adjusted Closing Price for Verrica Pharmaceuticals Inc (VRCA)

Loading...

Unadjusted Closing Price for Verrica Pharmaceuticals Inc (VRCA)

Loading...

Share Trading Volume for Verrica Pharmaceuticals Inc Shares

Loading...

Compare Performance of Verrica Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for VRCA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Verrica Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing VRCA

Symbol Name VRCA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Verrica Pharmaceuticals Inc (VRCA) Stock

Based on ratings from 3 analysts Verrica Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on VRCA's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for VRCA is USD 9.75 over the next 12 months. The maximum analyst target price is USD 13 while the minimum anlayst target price is USD 8.

Unfortunately we do not have enough data on VRCA's stock to indicate if its overvalued.

The last closing price of VRCA's stock was USD 5.65.

The most recent market capitalization for VRCA is USD 0.21B.

Based on targets from 3 analysts, the average taret price for VRCA is projected at USD 9.75 over the next 12 months. This means that VRCA's stock price may go up by +72.57% over the next 12 months.

We can't find any ETFs which contains Verrica Pharmaceuticals Inc's stock.

As per our most recent records Verrica Pharmaceuticals Inc has 100 Employees.

Verrica Pharmaceuticals Inc's registered address is 44 West Gay Street, West Chester, PA, United States, 19380. You can get more information about it from Verrica Pharmaceuticals Inc's website at https://www.verrica.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...